Dexmedetomidine Hydrochlorid · 2,345 days since initial FDA posting
Brand: DEXMEDETOMIDINE HYDROCHLORIDE
FDA lists Dexmedetomidine Hydrochlorid as Active Shortage (Gland Pharma Limited).
Availability on file: Available
Dexmedetomidine Hydrochloride Injection: Active Shortage
Available Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Dexmedetomidine Hydrochloride Injection
- Manufacturer
- Gland Pharma Limited
- Dosage Form
- Injection
- Presentation
- Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 43598-976-58)
- Package NDC
- 43598-976-58
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Apr 10, 2020
- Last Updated
- Sep 29, 2025
- Therapeutic Category
- Anesthesia
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Distributed by DRL
Nearby, Other Dexmedetomidine Shortage Records
Dexmedetomidine Hydrochloride Injection
Gland Pharma Limited
Injection
Dexmedetomidine Hydrochloride Injection
Gland Pharma Limited
Injection
Dexmedetomidine Hydrochloride Injection
Slayback Pharma
Injection
Dexmedetomidine Hydrochloride Injection
Slayback Pharma
Injection
Dexmedetomidine Hydrochloride Injection
Meitheal Pharmaceuticals, Inc.
Injection
Dexmedetomidine Hydrochloride Injection
HQ Specialty Pharma
Injection
FDA reason on file: Distributed by DRL. General shortage guidance lives on the tracker hub.